1-5 of 5
Binod Dhakal
Close
Sort by
Journal Articles

Outpatient Administration of CAR T-cell Therapies Using a Strategy of No Remote Monitoring and Early CRS Intervention

Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S. Fenske, Faiqa Farrukh, Walter Longo, Othman Salim Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N. Shah, Mehdi Hamadani
Journal: Blood Advances
Blood Adv bloodadvances.2024013239.
https://doi.org/10.1182/bloodadvances.2024013239
Published: 2024
Includes: Supplemental data
Journal Articles

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy

Ariel Kleman, Arun Singavi, Lauren Pommert, Angela J. Mathison, Parameswaran Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer M. Knight, Mithun V. Shah, Carolina Schinke, Robert Burns, George Francis Steinhardt, Sridhar Rao, Karen Carlson
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5549–5553.
https://doi.org/10.1182/bloodadvances.2022008953
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma

Ankit Kansagra, Angela Dispenzieri, Raphael Fraser, Noel Estrada-Merly, Surbhi Sidana, Taiga Nishihori, Doris K. Hansen, Larry D. Anderson, Jr., Rahul Banerjee, Naresh Bumma, Binod Dhakal, Jack Khouri, Heather Landau, Cindy Lee, Hira Mian, Sunita Nathan, Bipin Savani, Shaji Kumar, Muzaffar Qazilbash, Nina Shah, Anita D’Souza
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3991–3995.
https://doi.org/10.1182/bloodadvances.2022007218
Published: 2022
Includes: Supplemental data
Journal Articles

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma

Clinical Trials & Observations
Meera Mohan, Sneha Nagavally, Binod Dhakal, Sabarinath Venniyil Radhakrishnan, Saurabh Chhabra, Anita D’Souza, Parameswaran Hari
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2466–2470.
https://doi.org/10.1182/bloodadvances.2021006178
Published: 2022
Includes: Supplemental data
Journal Articles

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Clinical Trials & Observations
Jennifer M. Knight, J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza, Brent R. Logan, Mehdi Hamadani, Saurabh Chhabra, Binod Dhakal, Nirav Shah, Deepika Sriram, Mary M. Horowitz, Steve W. Cole
Journal: Blood Advances
Blood Adv (2020) 4 (3): 467–476.
https://doi.org/10.1182/bloodadvances.2019000765
Published: 2020
Includes: Supplemental data